'Novartis' diaporamas de présentation

Diabetes Medications

Diabetes Medications. An in-depth look at the medications used to treat diabetes. Type 1 Usually diagnosed in children and young adults People with type 1 diabetes do not make insulin. Type 1 Diabetes.

1.34k views • 90 slides

Workshop Objectives

Action Learning in Action - A Powerful New Tool for Solving Problems and Building Leaders, Teams and Organizations Michael J. Marquardt Professor, George Washington University Director, Global Institute of Action Learning. Workshop Objectives.

604 views • 38 slides

BY Narendra B Zaveri, Advocate E-mail: narendraz@vsnl.net Tel: (022) 25163461 (Res) Sunflower, Rajawadi, Ghatkoper(E) M

478 views • 28 slides

353 views • 24 slides

Innovation Dilemma - the case of antimicrobials -

346 views • 23 slides

Bandung, 9 December 2012

Novartis Indonesia Commit to increase accessibility of innovative medicine to more Indonesian Dr Luthfi Mardiansyah CPO Head & Country President Novartis Group Indonesia. Bandung, 9 December 2012.

360 views • 22 slides

Bandung, 9 December 2012

Novartis Indonesia Commit to increase accessibility of innovative medicine to more Indonesian Dr Luthfi Mardiansyah CPO Head & Country President Novartis Group Indonesia. Bandung, 9 December 2012.

223 views • 22 slides

PsicoMedica Research Group

PsicoMedica Research Group. Institutional Presentation Sergio Gloger M.D. sergio.gloger@psicomedica.cl www.psicomedica.com June 2005. June 2005. Mission. To perform research activities based on GCP/ICH and fulfilling FDA/EMEA/local regulations standards

255 views • 17 slides

Novartis in Italy

Novartis in Italy. Dimensions, role and resources. Commitment to innovation. Novartis 2012 data. Novartis is a global leader in the area of healthcare. Novartis is based in Basel and present in more than 140 countries. Profile of a protagonist Divisions.

641 views • 14 slides

BUS6900 IP Strategy and Management NOVARTIS GROUP

BUS6900 IP Strategy and Management NOVARTIS GROUP. Jian Gu Sedem Yener Elias Jaime Porras. Context. About Novartis Company IP Portfolio IP strategy and management Future plan for Novartis Company. About Novartis Company. multinational pharmaceutical company

549 views • 12 slides

BioLife Plasma Services Experience with HBV NAT Testing

508 views • 11 slides

PARTICIPATION IN ALLIANCES AND CONTRACTS

PARTICIPATION IN ALLIANCES AND CONTRACTS . 15% of producers surveyed currently market at least a portion of their calves through an alliance or coop. Number of calves marketed by participants is increasing at an average annual rate of 11%.

179 views • 11 slides

CORPORATE SOCIAL RESPOSIBILITY

CORPORATE SOCIAL RESPOSIBILITY. PRESENTED BY D SHREE VENKATESH sreevenkatesh@hotmail.com.

160 views • 9 slides

The P-4 NSABP Trial: NCAB Subcommittee Recommendations

The P-4 NSABP Trial: NCAB Subcommittee Recommendations. Bruce A. Chabner, MD June 16, 2007. Prior NCI-Sponsored Breast Cancer Prevention Trials. P-1: Tam vs Placebo. 13,388 women, Gail Risk 1.67 or higher. 49% reduction in invasive breast cancer over 5 yrs (3.3% vs. 1.7%)

247 views • 8 slides

American Association of Chinese in Toxicology Presents Distinguished Chinese Toxicologist Lecture

American Association of Chinese in Toxicology Presents Distinguished Chinese Toxicologist Lecture Raymond Yang, Ph.D. "Why is it important to develop 'Computational Toxicology'? Why is it particularly important for Chinese Toxicologists?". American Association of Chinese in Toxicology

74 views • 7 slides

244 views • 6 slides

Practice Management Rotation

124 views • 2 slides

Novartis Chem Ops Grimsby & Pharm Ops Horsham Power network simulation and analysis

Novartis Chem Ops Grimsby & Pharm Ops Horsham Power network simulation and analysis. EUR 60k Initial project value. Solutions implemented: Analysis of power distribution network at both sites Steady state modelling of network using PSS Sincal software

233 views • 2 slides

Delhi HC upholds order restricting sale of Cipla's respiratory disease drug

Delhi HC upholds order restricting sale of Cipla's respiratory disease drug on Business Standard. Cipla's Unibrez costs Rs 130 per pack of ten tablets, compared with Rs 677 for Onbrez

79 views • 2 slides

88 views • 1 slides